Результати пошуку - Alain Baron
- Показ 1 - 20 результатів із 24
- На наступну сторінку
-
1
Improving apple juice expression and quality by pulsed electric field on an industrial scale за авторством Mohammad Turk, Eugène Vorobiev, Alain Baron
Опубліковано 2012Artigo -
2
Insulin resistance in the vasculature за авторством Kieren J. Mather, Helmut O. Steinberg, Alain Baron
Опубліковано 2013Carta -
3
Endothelin Limits Insulin Action in Obese/Insulin-Resistant Humans за авторством Amale Lteif, Prashant Vaishnava, Alain Baron, Kieren J. Mather
Опубліковано 2007Artigo -
4
-
5
Antiobesity Effects of the β-Cell Hormone Amylin in Diet-Induced Obese Rats: Effects on Food Intake, Body Weight, Composition, Energy Expenditure, and Gene Expression за авторством Jonathan D. Roth, Heather Hughes, Eric S. Kendall, Alain Baron, Christen M. Anderson
Опубліковано 2006Artigo -
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans за авторством Arie Katz, Sridhar Nambi, Kieren J. Mather, Alain Baron, Dean Follmann, Gail W. Sullivan, Michael J. Quon
Опубліковано 2000Artigo -
14
Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure за авторством Que Liu, Christen M. Anderson, Anatoly Broyde, Clara J. Polizzi, Rayne Fernandez, Alain Baron, David G. Parkes
Опубліковано 2010Artigo -
15
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials за авторством Ralph A. DeFronzo, John B. Buse, Terri Kim, Colleen Burns, Sharon Skare, Alain Baron, Mark Fineman
Опубліковано 2016Artigo -
16
Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes за авторством Mark Fineman, Thomas A. Bicsak, Larry Z. Shen, Kristin Taylor, Eling Gaines, Amanda Varns, Dennis Kim, Alain Baron
Опубліковано 2003Artigo -
17
Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea за авторством David M. Kendall, Matthew C. Riddle, Julio Rosenstock, Dongliang Zhuang, Dennis Dong Hwan Kim, Mark Fineman, Alain Baron
Опубліковано 2005Artigo -
18
The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies за авторством John B. Buse, Ralph A. DeFronzo, Julio Rosenstock, Terri Kim, Colleen Burns, Sharon Skare, Alain Baron, Mark Fineman
Опубліковано 2015Artigo -
19
-
20
Інструменти для пошуку:
Пов'язані теми
Endocrinology
Internal medicine
Medicine
Diabetes mellitus
Insulin
Type 2 diabetes
Insulin resistance
Exenatide
Alternative medicine
Pathology
Placebo
Gastroenterology
Biology
Obesity
Receptor
Vasodilation
Blood pressure
Endothelial dysfunction
Glycemic
Islet
Metformin
Postprandial
Adverse effect
Amylin
Biochemistry
Chemistry
Endothelin receptor
Endothelium
Gastric emptying
Pharmacology